inCytes™ Teaser

Published by Nicolas Tierney

November 6, 2019

Share This Page
View as PDF

inCytes™ Teaser

November 6, 2019

Published by Nicolas Tierney

Abstract

Healthcare is about telling stories.  Patients telling stories to doctors, doctors sharing stories with colleagues, and organizations building stories around their brands.  The most effective stories are grounded in facts, and in today’s modern world, such evidence has never been easier to discover.

inCytes™ is a clinical evidence application, yet it so much more.  Through its engaging interfaces, user-specific experiences, and social collaboration, inCytes™ is a tool for building and sharing stories.

DOWNLOAD WHITE PAPER

Share This Page

inCytes™ Teaser

Published by Nicolas Tierney

November 6, 2019

Abstract

Healthcare is about telling stories.  Patients telling stories to doctors, doctors sharing stories with colleagues, and organizations building stories around their brands.  The most effective stories are grounded in facts, and in today’s modern world, such evidence has never been easier to discover.

inCytes™ is a clinical evidence application, yet it so much more.  Through its engaging interfaces, user-specific experiences, and social collaboration, inCytes™ is a tool for building and sharing stories.

DOWNLOAD WHITE PAPER

Share This Page

Read The Latest

May 8, 2025

Generating Clinical, Scientific, And Financial Value In The Field Of Spinal Muscular Atrophy (SMA)

Discover how RegenMed Circles is transforming SMA treatment by enabling clinicians to share real-world outcomes, refine therapies, and improve patient results — while fostering collaboration and innovation. Ready to lead the future of SMA care? Read more to see how you can make an impact.

May 7, 2025

Cystic Fibrosis: Advances In Clinical Management And Emerging Therapies

Cystic fibrosis (CF) is a complex, multisystem condition driven by mutations in the CFTR gene. While CFTR modulators have transformed care for many, a significant subset of patients — particularly those with rare or unresponsive mutations — remain underserved...

May 6, 2025

Introducing Our New Principal Investigator: Dr. Marcus Klingenberg

RegenMed is proud to announce that Dr. Marcus Klingenberg will be acting as a Principal Investigator for four separate Physicians-Owned Circles in the field of micronized adipose tissue therapies for musculoskeletal indications. Dr. Klingenberg is an internationally recognized orthopedic surgeon...